Evaluate your bio clones, strains, and viral constructs with scalable flexibility using our advanced cell culture bioreactors. Our platform ensures efficient clone screening systems for optimal performance.

Accelerate timelines, optimize performance, and reduce risks in bringing biotherapeutics to market with our upstream process development services and advanced bioreactor technology. By focusing on cell culture media optimization and development, we can help ensure your experiments deliver efficient and reproducible outcomes.

Use our advanced bioreactors and Design of Experiments (DoE) expertise to perform cell culture process characterization prior to PPQ. Assess your upstream process in scale-down bioreactors that allow for enhanced model curvature, deeper variable exploration, and more robust process characterization development.

Scaling a bioprocess from R&D to manufacturing is challenging. Bioprocess modeling and simulation enables precise control over process conditions, improving efficiency and reducing variability. Our services offer a bioprocess digital twin approach to streamline development, leveraging advanced modeling to simulate and optimize conditions before running costly experiments.

Run multiple experiments using our parallel bioreactor systems, which are cloud-connected 250mL and 5L bioreactors managed in our facility for high-throughput optimization to ensure process consistency, accelerated development, and seamless scalability. For those seeking an in-house solution, Stratyx250 provides a disposable 250mL bioreactor that users can implement directly in their own labs for greater control. While you will be limited on the number of experiments you can run on your own, you can pair our Stratyx platform running in your lab with the bioreactors running in ours.